NGF and osteoarthritis: Recently, the European Commission authorized a different anti-NGF mAb (bedinvetmab) for the alleviation of osteoarthritis pain in dogs1 In cats, a felinized anti-NGF mAb (frunevetmab) was developed and assessed for preliminary safety and efficacy in a feline model of chronic pain (26).